Henry Schein, Inc. (NASDAQ:HSIC) Position Boosted by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 611.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,695 shares of the company’s stock after acquiring an additional 11,771 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Henry Schein were worth $1,034,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Everett Harris & Co. CA grew its stake in Henry Schein by 29.1% during the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock valued at $7,925,000 after acquiring an additional 23,622 shares in the last quarter. KBC Group NV grew its stake in shares of Henry Schein by 163.5% in the 4th quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after buying an additional 323,901 shares in the last quarter. Duality Advisers LP bought a new stake in shares of Henry Schein in the 4th quarter valued at approximately $1,561,000. Sprucegrove Investment Management Ltd. grew its stake in shares of Henry Schein by 14.2% in the 4th quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock valued at $16,693,000 after buying an additional 27,500 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its stake in shares of Henry Schein by 64.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock valued at $3,138,000 after buying an additional 16,241 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of HSIC stock traded up $0.30 during trading hours on Wednesday, reaching $70.29. 1,425,823 shares of the company’s stock were exchanged, compared to its average volume of 1,105,807. The business has a fifty day moving average price of $68.28 and a 200-day moving average price of $71.92. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $9.00 billion, a P/E ratio of 23.75, a P/E/G ratio of 1.75 and a beta of 0.87. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. Henry Schein’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the company posted $1.21 earnings per share. Analysts predict that Henry Schein, Inc. will post 5.16 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of several recent research reports. Piper Sandler reissued an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a research note on Friday, June 21st. Evercore ISI lowered their price target on Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research note on Tuesday, July 9th. Barrington Research restated an “outperform” rating and issued a $92.00 target price on shares of Henry Schein in a report on Friday, July 5th. Robert W. Baird upgraded Henry Schein from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $81.00 to $92.00 in a report on Monday. Finally, Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday. One analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $81.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.